HIGHLIGHTS OF PRESCRIBING INFORMATIONThese highlights do not include all the... |

alfentanil injection, USP
alfentanil injection, USP Quick Finder
WARNING: ADDICTION, ABUSE, AND MISUSE
Addiction, Abuse, and Misuse
Alfentanil injection exposes patients and...
1 INDICATIONS AND USAGE
Alfentanil injection is indicated:
- as an analgesic adjunct given in incremental doses in the maintenance of anesthesia with barbiturate/nitrous oxide/oxygen.
- as an...
2 DOSAGE AND ADMINISTRATION
2.1 Important Dosage and Administration Instructions
Alfentanil injection should be administered only by persons specifically trained in...
3 DOSAGE FORMS AND STRENGTHS
Alfentanil Injection USP, for intravenous use (equivalent to 500 mcg/mL alfentanil base).
4 CONTRAINDICATIONS
Alfentanil injection is contraindicated in patients with:
- Hypersensitivity to alfentanil (e.g., anaphylaxis) [see Adverse Reactions (6)]...
5 WARNINGS AND PRECAUTIONS
5.1 Addiction, Abuse, and Misuse
Alfentanil injection contains alfentanil, a Schedule II controlled substance. As an opioid, alfentanil...
7 DRUG INTERACTIONS
Table 2 includes clinically significant drug interactions with alfentanil injection.
8 USE IN SPECIFIC POPULATIONS
8.1 Pregnancy
Risk Summary
Prolonged use of opioid...
9 DRUG ABUSE AND DEPENDENCE
9.1 Controlled Substance
Alfentanil injection contains alfentanil, a Schedule II controlled substance.
10 OVERDOSAGE
Clinical Presentation
Acute overdose with alfentanil injection can be manifested by respiratory depression, somnolence...
11 DESCRIPTION
Alfentanil Injection, USP contains alfentanil, an opioid agonist, chemically designated as N- [1- [2-(4-ethyl-4,5-dihydro-5-oxo-1H-tetrazol-1- yl) ethyl]-4-(methoxymethyl)-4-piperidinyl]-N-phenylpropanamide...
12 CLINICAL PHARMACOLOGY
12.1 Mechanism of Action
Alfentanil injection is an opioid agonist. The principal actions of therapeutic value are analgesia and sedation....
13 NONCLINICAL TOXICOLOGY
13.1 Carcinogenesis, Mutagenesis, Impairment of Fertility
...
16 HOW SUPPLIED/STORAGE AND HANDLING
HOW SUPPLIED
Alfentanil Injection, USP for intravenous use contains alfentanil hydrochloride equivalent to 500 mcg/mL of...
To report an adverse event related to Pfizer-BioNTech COVID-19 Vaccine (also known as COMIRNATY®, COVID-19 mRNA, Vaccine BNT162b2 or BNT162) or Pfizer COVID-19 Treatment (also known as PAXLOVID™ (nirmatrelvir tablets; ritonavir tablets)), and you are not part of a clinical trial* for this product, click the link below to submit your information:
*If you are involved in a clinical trial for either product, adverse events should be reported to your coordinating study site.
If you cannot use the above website or would like to report an adverse event related to a different Pfizer product, please call Pfizer Safety at(800) 438-1985.
(800)-332-1088.